NKI-AvL
NKI-AvL
Amsterdam, Netherlands5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 1 / Phase 2 | 2026-03-10 | NCT07460180 | |
| Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2024-05-30 | NCT03815890 | |
| Blood Sampling of Healthy Volunteers for Immunological Research | Healthy Volunteers | Recruiting | Not applicable | 2023-03-23 | NCT03819829 | |
| Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize) | Locally Advanced, Squamous Cell Carcinoma of the Vulva | Recruiting | Phase 2 | 2022-10-19 | NCT04192253 | |
| Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy | Metastatic Squamous Cell Carcinoma of the Vulva | Recruiting | Phase 2 | 2022-10-19 | NCT04161664 |